Intel (NASDAQ:INTC – Free Report) had its target price lowered by Northland Securities from $42.00 to $28.00 in a research report report published on Friday, Benzinga reports. The firm currently has an outperform rating on the chip maker’s stock.
Other equities research analysts have also issued research reports about the stock. StockNews.com lowered shares of Intel from a “hold” rating to a “sell” rating in a report on Friday, August 9th. Argus downgraded Intel from a “buy” rating to a “hold” rating in a report on Tuesday, August 6th. Roth Mkm lowered their price target on Intel from $35.00 to $25.00 and set a “neutral” rating for the company in a research note on Friday, August 2nd. HSBC lowered shares of Intel from a “hold” rating to a “reduce” rating in a research note on Friday, August 2nd. Finally, Robert W. Baird upped their target price on shares of Intel from $20.00 to $25.00 and gave the company a “neutral” rating in a research note on Friday. Six analysts have rated the stock with a sell rating, twenty-five have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $30.12.
Read Our Latest Report on Intel
Intel Stock Down 2.9 %
Intel (NASDAQ:INTC – Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The chip maker reported ($0.46) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.44). Intel had a negative return on equity of 1.71% and a negative net margin of 29.42%. The business had revenue of $13.30 billion for the quarter, compared to analyst estimates of $13.02 billion. During the same quarter in the prior year, the firm earned $0.28 EPS. The firm’s quarterly revenue was down 6.3% on a year-over-year basis. As a group, equities research analysts anticipate that Intel will post -0.47 EPS for the current year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Capital International Investors boosted its position in Intel by 16.0% during the first quarter. Capital International Investors now owns 112,093,582 shares of the chip maker’s stock worth $4,951,174,000 after purchasing an additional 15,475,631 shares during the period. Van ECK Associates Corp raised its holdings in shares of Intel by 60.5% during the 2nd quarter. Van ECK Associates Corp now owns 34,591,800 shares of the chip maker’s stock worth $1,071,308,000 after buying an additional 13,035,566 shares in the last quarter. Davis Selected Advisers grew its position in Intel by 86.2% in the second quarter. Davis Selected Advisers now owns 12,642,316 shares of the chip maker’s stock valued at $391,533,000 after acquiring an additional 5,851,098 shares during the last quarter. Caxton Associates LP bought a new position in shares of Intel in the second quarter worth about $162,592,000. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of Intel by 2,681.1% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 4,431,749 shares of the chip maker’s stock valued at $137,251,000 after purchasing an additional 4,272,395 shares in the last quarter. Institutional investors own 64.53% of the company’s stock.
About Intel
Intel Corporation designs, develops, manufactures, markets, and sells computing and related products and services worldwide. It operates through Client Computing Group, Data Center and AI, Network and Edge, Mobileye, and Intel Foundry Services segments. The company's products portfolio comprises central processing units and chipsets, system-on-chips (SoCs), and multichip packages; mobile and desktop processors; hardware products comprising graphics processing units (GPUs), domain-specific accelerators, and field programmable gate arrays (FPGAs); and memory and storage, connectivity and networking, and other semiconductor products.
Featured Stories
- Five stocks we like better than Intel
- Why Are These Companies Considered Blue Chips?
- Intel: Is Now the Time to Be Brave?Â
- Transportation Stocks Investing
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What is a Bond Market Holiday? How to Invest and Trade
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Intel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intel and related companies with MarketBeat.com's FREE daily email newsletter.